2,513
+1.25%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in JPY, from our data supplier.
Revenue
¥133.15bn
FY2017FY2026
Net income
¥3.65bn
FY2017FY2026
Free cash flow
−¥3.85bn
FY2017FY2026
Shareholders' equity
¥32.86bn
FY2017FY2026
Income statement
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ¥133.15bn | ¥121.24bn | ¥108.54bn | ¥104.78bn | ¥91.86bn | ¥82.67bn | ¥93.37bn | ¥100.65bn | ¥94.99bn | ¥83.80bn |
| Gross profit | ¥18.47bn | ¥16.93bn | ¥15.47bn | ¥13.79bn | ¥11.45bn | ¥9.69bn | ¥10.81bn | ¥11.66bn | ¥10.83bn | ¥9.45bn |
| Operating income | ¥5.00bn | ¥4.74bn | ¥4.43bn | ¥3.80bn | ¥2.74bn | ¥1.93bn | ¥2.45bn | ¥3.33bn | ¥2.94bn | ¥2.36bn |
| Net income | ¥3.65bn | ¥2.97bn | ¥2.95bn | ¥2.91bn | ¥2.25bn | ¥1.47bn | ¥1.69bn | ¥2.33bn | ¥1.91bn | ¥1.61bn |
| Diluted earnings per share | 321.14 | 261.80 | 256.86 | 250.45 | 192.83 | 124.62 | 143.66 | 197.89 | 162.42 | 136.95 |
Balance sheet
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | ¥78.82bn | ¥74.16bn | ¥66.06bn | ¥64.11bn | ¥56.64bn | ¥50.96bn | ¥51.97bn | ¥55.52bn | ¥53.78bn | ¥45.90bn |
| Cash and short-term investments | ¥8.19bn | ¥10.26bn | ¥7.90bn | ¥8.43bn | ¥8.17bn | ¥7.28bn | ¥5.40bn | ¥5.14bn | ¥5.90bn | ¥5.88bn |
| Total liabilities | ¥45.38bn | ¥43.46bn | ¥37.86bn | ¥38.11bn | ¥32.85bn | ¥29.31bn | ¥31.99bn | ¥36.60bn | ¥36.50bn | ¥30.85bn |
| Debt | ¥18.22bn | ¥15.22bn | ¥12.51bn | ¥14.63bn | ¥11.95bn | ¥9.43bn | ¥11.63bn | ¥13.47bn | ¥15.17bn | ¥12.01bn |
| Shareholders' equity | ¥32.86bn | ¥29.89bn | ¥27.41bn | ¥25.23bn | ¥23.04bn | ¥20.83bn | ¥19.41bn | ¥18.37bn | ¥16.77bn | ¥14.85bn |
| Shares outstanding | 11m | 11m | 11m | 12m | 12m | 12m | 12m | 12m | 12m | 12m |
Cash flow
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −¥3.62bn | ¥251.2m | ¥3.60bn | −¥96.8m | −¥539.2m | ¥4.57bn | ¥3.67bn | ¥2.93bn | −¥2.25bn | ¥2.14bn |
| Capital spending | −¥226.9m | −¥284.1m | −¥471.2m | −¥1.45bn | −¥534.2m | −¥518.7m | −¥1.37bn | −¥1.51bn | −¥644.1m | −¥258.0m |
| Free cash flow | −¥3.85bn | −¥32.9m | ¥3.13bn | −¥1.54bn | −¥1.07bn | ¥4.06bn | ¥2.30bn | ¥1.42bn | −¥2.90bn | ¥1.88bn |
| Dividends paid | −¥1.02bn | −¥970.1m | −¥924.7m | −¥821.6m | −¥588.0m | −¥392.9m | −¥408.1m | −¥368.2m | −¥314.9m | −¥298.6m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ¥29.98bn | ¥46.37bn | ¥34.46bn | ¥28.03bn | ¥24.29bn | ¥44.46bn | ¥28.39bn | ¥26.50bn |
| Gross profit | ¥4.16bn | ¥6.34bn | ¥4.77bn | ¥3.89bn | ¥3.47bn | ¥6.01bn | ¥3.88bn | ¥3.79bn |
| Operating income | ¥962.0m | ¥2.03bn | ¥1.70bn | ¥915.6m | ¥340.9m | ¥2.12bn | ¥1.24bn | ¥899.0m |
| Net income | ¥552.6m | ¥1.56bn | ¥1.34bn | ¥713.2m | ¥35.1m | ¥1.21bn | ¥1.02bn | ¥365.0m |
| Diluted earnings per share | 48.60 | 137.43 | 118.03 | 62.80 | 3.09 | 106.71 | 88.54 | 31.81 |
| Total assets | ¥75.82bn | ¥78.82bn | ¥69.97bn | ¥60.55bn | ¥63.51bn | ¥74.16bn | ¥64.48bn | ¥59.88bn |
| Cash and short-term investments | ¥6.51bn | ¥8.19bn | ¥6.43bn | ¥7.32bn | ¥6.61bn | ¥10.26bn | ¥6.28bn | ¥8.51bn |
| Debt | ¥19.83bn | ¥18.01bn | ¥14.19bn | ¥9.79bn | ¥13.15bn | ¥15.02bn | ¥12.90bn | ¥10.65bn |
| Shareholders' equity | ¥33.33bn | ¥32.86bn | ¥30.69bn | ¥29.54bn | ¥28.88bn | ¥29.89bn | ¥28.34bn | ¥28.42bn |
Financial ratios
Data as of 22 Sept 2026
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 13.9% | 14.0% | 14.2% | 13.2% | 12.5% | 11.7% |
| Operating margin | 3.8% | 4.0% | 4.6% | 3.6% | 3.0% | 2.3% |
| Net margin | 2.7% | 2.5% | 2.7% | 2.8% | 2.5% | 1.8% |
| Return on equity | 11.1% | 9.9% | 10.8% | 11.5% | 9.8% | 7.0% |
| Return on assets | 4.6% | 4.0% | 4.5% | 4.5% | 4.0% | 2.9% |
| Free cash flow yield | -10.1% | 1.6% | 12.0% | 3.9% | -0.0% | 14.7% |
| Revenue growth | 9.8% | 11.7% | 3.6% | 14.1% | 11.1% | -11.5% |
| Earnings growth | 22.8% | 0.9% | 1.5% | 29.0% | 53.5% | -13.2% |
| Current ratio | 1.68x | 1.63x | 1.57x | 1.59x | 1.69x | 1.63x |
| Debt to equity | 0.55x | 0.50x | 0.45x | 0.57x | 0.51x | 0.45x |
| Equity ratio | 41.7% | 40.3% | 41.5% | 39.4% | 40.7% | 40.9% |
| Interest coverage | 24.61x | 37.92x | 53.44x | 39.01x | 26.67x | 25.35x |
| Buybacks as a share of market value | -0.1% | 1.0% | 1.1% | 0.7% | 0.8% | -0.0% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 8.3% | 10.0% | 4.6% |
| Operating income | 9.5% | 20.9% | 6.4% |
| Net income | 7.9% | 20.0% | 8.5% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 13.9% | 13.8% | 13.4% | 12.6% |
| Operating margin | 3.8% | 3.8% | 3.5% | 3.3% |
| Net margin | 2.6% | 2.7% | 2.5% | 2.3% |
Valuation history
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 8.0 | 8.7 | 7.3 | 7.5 | 7.7 | 10.9 | 5.8 | 4.5 | 5.4 | 11.6 |
| Price to sales | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 |
Dividends and splits
Per share, in the currency the company pays
Paid for 36 years. Last went ex-dividend on 30 Mar 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 144.00 | 85.00 | 80.00 | 70.00 | 40.00 | 33.333 | 34.667 | 31.333 |
- 1.5-for-1 split · 29 Dec 2021
- 1.1-for-1 split · 27 Mar 2007
- 1.05-for-1 split · 26 Sept 2006
- 1.1-for-1 split · 28 Mar 2006
- 1.05-for-1 split · 27 Sept 2005
- 1.1-for-1 split · 28 Mar 2005
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.